Overview

Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells

Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
The current study describes a randomized, double-blind, cross-over study of intravenous G-CSF followed by infusion with autologous mobilized peripheral blood mononuclear cells (mPBMCs) in children with cerebral palsy (CP) to determine the safety and feasibility of the procedure, as well as the potential efficacy for improving neurological impairment.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Hanyang University Seoul Hospital
Collaborator:
Ministry of Health & Welfare, Korea
Treatments:
Lenograstim